There are several levers CVS pulled this quarter, and thanks to the help of some acquired pharmacies, the stock in enjoying a little pop after earnings.
With MercadoLibre, growth numbers look good, particularly if you focus on non-currency metrics like registered users, items sold, and transactions on MercadoPago.
A transcript follows the video.
This podcast was recorded on May 6, 2016.
Chris Hill: First-quarter profit and revenue for CVS Health coming in a little bit higher than expected, and the stock moving a little bit higher, too, Ron.
Ron Gross: The company is doing well, benefiting from all those Target pharmacies they took on, and the acquisition of Omnicare. Same-store sales are up 4%. Margins took a hit, what we call reimbursement pressure continuing to weigh, some of their product mix hurting margins. So, adjusted EPS was only up 4%, but pretty good. Guidance a bit weak, but reiterated full-year. So I would say everything's on track, company continues to execute well.
Hill: MercadoLibre is the most popular e-commerce business in Latin America. First-quarter results were surprising, but in a good way, Matty.
Matt Argersinger: Surprising in a good way. It's tough to follow the top-line earnings results for this company, because the currencies they deal with in Latin America are so volatile against the U.S. dollar. Three metrics I really like to use -- if you look at registered users, those are up 20% to 152 million. They're by far the leader in e-commerce in the region. Items sold is kind of my proxy for revenue growth up 39% to 38 million units. Also, transactions on MercadoPago, which is their PayPal-like platform, up 86% to 27.5 million, which gives you an idea of the velocity of transactions across MercadoLibre's platform. I love this company. I think if you really want to play e-commerce in emerging markets, this is probably your best bet.
Matthew Argersinger owns shares of MercadoLibre. Ron Gross has no position in any stocks mentioned. Chris Hill has no position in any stocks mentioned. The Motley Fool owns shares of and recommends MercadoLibre and PayPal Holdings. The Motley Fool recommends CVS Health. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.